Leveraging Genomic, Preclinical, and Drug Response Data in the Age of AI
Join Dr. Michael Boice from Certis Oncology for a discussion and demonstration of how artificial intelligence can improve preclinical decision-making in cancer research.
Towards Eliminating Small Molecule Toxicity: Axiom’s AI Models for Clinical Safety Assessment
Join Axiom’s webinar to explore how AI/ML enhances clinical toxicity assessments, delivering accurate, cost-effective DILI risk predictions at human exposure levels.

